270 related articles for article (PubMed ID: 35421361)
1. The context-dependent, combinatorial logic of BMP signaling.
Klumpe HE; Langley MA; Linton JM; Su CJ; Antebi YE; Elowitz MB
Cell Syst; 2022 May; 13(5):388-407.e10. PubMed ID: 35421361
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial Signal Perception in the BMP Pathway.
Antebi YE; Linton JM; Klumpe H; Bintu B; Gong M; Su C; McCardell R; Elowitz MB
Cell; 2017 Sep; 170(6):1184-1196.e24. PubMed ID: 28886385
[TBL] [Abstract][Full Text] [Related]
3. Ligand-receptor promiscuity enables cellular addressing.
Su CJ; Murugan A; Linton JM; Yeluri A; Bois J; Klumpe H; Langley MA; Antebi YE; Elowitz MB
Cell Syst; 2022 May; 13(5):408-425.e12. PubMed ID: 35421362
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
5. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
6. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein receptor signal transduction in human disease.
Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
[TBL] [Abstract][Full Text] [Related]
8. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
9. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
11. Specification of BMP Signaling.
Nickel J; Mueller TD
Cells; 2019 Dec; 8(12):. PubMed ID: 31817503
[TBL] [Abstract][Full Text] [Related]
12. DRAGON, a bone morphogenetic protein co-receptor.
Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
[TBL] [Abstract][Full Text] [Related]
13. Heterodimer-heterotetramer formation mediates enhanced sensor activity in a biophysical model for BMP signaling.
Karim MS; Madamanchi A; Dutko JA; Mullins MC; Umulis DM
PLoS Comput Biol; 2021 Sep; 17(9):e1009422. PubMed ID: 34591841
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuned shuttles for bone morphogenetic proteins.
Wharton KA; Serpe M
Curr Opin Genet Dev; 2013 Aug; 23(4):374-84. PubMed ID: 23735641
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
16. The Drosophila type II receptor, Wishful thinking, binds BMP and myoglianin to activate multiple TGFbeta family signaling pathways.
Lee-Hoeflich ST; Zhao X; Mehra A; Attisano L
FEBS Lett; 2005 Aug; 579(21):4615-21. PubMed ID: 16098524
[TBL] [Abstract][Full Text] [Related]
17. Cardiac looping and the vertebrate left-right axis: antagonism of left-sided Vg1 activity by a right-sided ALK2-dependent BMP pathway.
Ramsdell AF; Yost HJ
Development; 1999 Dec; 126(23):5195-205. PubMed ID: 10556046
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells.
Yew KH; Hembree M; Prasadan K; Preuett B; McFall C; Benjes C; Crowley A; Sharp S; Tulachan S; Mehta S; Tei E; Gittes G
J Biol Chem; 2005 Sep; 280(37):32209-17. PubMed ID: 16020542
[TBL] [Abstract][Full Text] [Related]
19. Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses.
Mazerbourg S; Sangkuhl K; Luo CW; Sudo S; Klein C; Hsueh AJ
J Biol Chem; 2005 Sep; 280(37):32122-32. PubMed ID: 16049014
[TBL] [Abstract][Full Text] [Related]
20. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
